Mediators of Inflammation / 2020 / Article / Tab 3

Research Article

Distinguishable Immunologic Characteristics of COVID-19 Patients with Comorbid Type 2 Diabetes Compared with Nondiabetic Individuals

Table 3

Status of cellular immunity in patients with and without type 2 diabetes.

VariablesNormal rangeNDM ()T2D () value
MedianIncreased no. (%)Decreased no. (%)MedianIncreased no. (%)Decreased no. (%)

T (%)56-8667.00 (0.0%)4 (12.1%)62.90 (0.0%)9 (23.1%)0.059
T (/μL)723-27379830 (0.0%)9 (27.3%)6790 (0.0%)19 (48.7%)
Th (%)33-5841.11 (3.0%)6 (18.2%)42.00 (0.0%)1 (2.6%)0.926
Th (/μL)404-16126040 (0.0%)8 (24.2%)4510 (0.0%)6 (15.4%)
Tc (%)13-3924.02 (6.1%)4 (12.1%)18.70 (0.0%)18 (46.2%)
Tc (/μL)220-11293280 (0.0%)12 (36.4%)2030 (0.0%)22 (66.7%)
Th/Tc0.9-2.02.1215 (45.5%)3 (9.1%)2.5422 (56.4%)0 (0.0%)0.221
B (%)5-2213.44 (12.1%)0 (0.0%)19.412 (30.8%)0 (0.0%)
B (/μL)80-6161871 (3.0%)2 (6.1%)170.31 (2.6%)5 (15.2%)0.384
NK (%)5-2617.32 (6.1%)0 (0.0%)16.43 (7.7%)3 (7.7%)0.810
NK (/μL)84-7242420 (0.00%)2 (6.1%)1861 (2.6%)14 (35.9%)

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.